The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (22 analysts) rates it buy, with a mean price target of $216. It reported earnings in this window, a natural checkpoint for the thesis.
American Tower AMT
Outside both standardsAn entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · American Tower Corporation is one of the largest global real estate investment trusts.
read at $168.07
American Tower holds its Markup at $168.07.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | Elevated stress, defensive posture warranted, held for 2 days |
| Price | $168.07 |
| Valuation | 27.11 trailing · 24.01 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.89 |
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades above our $161.01 fair value estimate, strong competitive moat, 4.70% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | 4.70% |
| Profit margin | 31.08% |
| Debt to equity | 438.72 |
| Analyst consensus | Buy · 23 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its debt ratio. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is 71.2% of its assets, above the one-third ceiling the screen allows. Fail
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 3.4% of assets, under the 49% limit. Pass
- Revenue purity Only 1.3% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Cell Towers Collect Rent But Debt Trips The Screen
Cell towers sit on hills and rooftops, quietly taking rent from every carrier that needs signal. American Tower owns a large chunk of that infrastructure and shows a strong moat, 27 percent profit margins and 30 percent ROE. We pass anyway.
The shares trade at 170 against our 157 fair value, an 8 percent premium, while forward earnings sit at 24.8 times and revenue grows just 7 percent. Analyst targets sit higher, yet the valuation leaves no margin once you strip out the growth already priced in.
Debt levels breach our ethical screen, and a REIT that must keep borrowing to expand towers carries real refinancing risk when rates stay elevated. The business itself is steady, but the combination of stretched price and leverage is enough to step aside.
Analysis, not advice.
| Forward P/E | 24.0x expensive even after accounting for its growth |
| Trailing P/E | 27.1x a premium valuation |
| Revenue growth | 4.7% slow but positive growth |
| Profit margin | 31.1% highly profitable on every dollar of sales |
| Return on equity | 33.9% an exceptional return on shareholder capital |
| Debt to equity | 4.39 heavy leverage — higher risk if revenue softens |
| Current ratio | 0.35 below 1 — short-term bills exceed liquid assets |
| Beta | 0.89 steadier than the market |
| Market cap | $78.3B |
| Employees | 4,866 |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on AMT
- › American Tower (AMT): Goldman Sachs Starts Coverage With a Buy and a $215 Target Insider Monkey · 15 Jul 2026
- › Here's What to Expect From American Tower's Next Earnings Report Barchart · 14 Jul 2026
- › The Real Risk in Retirement Isn’t Running Out of Money. It’s Losing Your Purchasing Power. 24/7 Wall St. · 14 Jul 2026
- › AST SpaceMobile’s Next Launches Could Decide Whether Its Rally Regains Orbit MarketBeat · 13 Jul 2026
- › American Tower (AMT) Surpasses Market Returns: Some Facts Worth Knowing Zacks · 10 Jul 2026
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in AMT's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
AMT trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (22 analysts) rates it buy, with a mean price target of $216. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (22 analysts) rates it buy, with a mean price target of $216. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (22 analysts) rates it buy, with a mean price target of $216. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (22 analysts) rates it buy, with a mean price target of $216. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (22 analysts) rates it buy, with a mean price target of $216. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (22 analysts) rates it buy, with a mean price target of $216. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 12.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (22 analysts) rates it buy, with a mean price target of $216. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (22 analysts) rates it buy, with a mean price target of $216.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (22 analysts) rates it buy, with a mean price target of $216.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-29 | DOWLING RUTH T | Officer | 972 | $173,092 | |
| 2026-03-10 | KALATHUR RAJESH | Director | 2,671 | $494,936 | |
| 2026-03-10 | REILLY EUGENE F | Director | 1,209 | · | |
| 2026-03-10 | MEYER ROBERT JOSEPH JR | Officer | 4,030 | · | |
| 2026-03-10 | TANNER BRUCE L | Director | 1,209 | · | |
| 2026-03-10 | KALATHUR RAJESH | Director | 1,209 | · | |
| 2026-03-10 | LIEBLEIN GRACE D | Director | 1,209 | · | |
| 2026-03-10 | RAY NEVILLE R. | Director | 1,209 | · | |
| 2026-03-10 | CHAMBLISS KELLY C. | Director | 1,209 | · | |
| 2026-03-10 | FONT JUAN HERNANDEZ | Officer | 8,060 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-05-11 | Dwight Evans | Democrat | Sale | 1K–15K |
| 1 May2026 | Ro Khanna | Democrat | sell | 1K–15K |
| 1 May2026 | Ro Khanna | Democrat | buy | 1K–15K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $177.47 | +8.5% | · | $1,085 | +8.5% |
| 2 months | $177.52 | +8.5% | $1.79 | $1,095 | +9.5% |
| 3 months | $178.08 | +8.1% | $1.79 | $1,091 | +9.1% |
| 6 months | $178.18 | +8.1% | $3.49 | $1,100 | +10.0% |
| 1 year | $206.97 | -7.0% | $6.89 | $964 | -3.6% |
| 2 years | $181.77 | +5.9% | $13.45 | $1,133 | +13.3% |
| 3 years | $168.83 | +14.1% | $19.96 | $1,259 | +25.9% |
| 5 years | $230.61 | -16.5% | $31.35 | $971 | -2.9% |
Historical returns from market close data. Past performance does not guarantee future results.